BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Nosology
,
Tamoxifen
,
rs6983267
,
FABP1
,
G-protein-coupled receptor binding
,
Influenza
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
Topical carbonic anhydrase inhibitors
Summary
General Info
Curated Studies
Most Correlated Studies
There were no matches for Topical carbonic anhydrase inhibitors
Explore Curated Studies Results
Literature
Most Relevant Literature
Meta-analysis of α2-adrenergic agonists versus carbonic anhydrase inhibitors as adjunctive therapy.
Topical carbonic anhydrase inhibitors and visual function in glaucoma and ocular hypertension.
Literature review and meta-analysis of topical carbonic anhydrase inhibitors and ocular blood flow.
Evaluation of adverse events in self-reported sulfa-allergic patients using topical carbonic anhydra…
Topical drug delivery to the eye: dorzolamide.
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Effects of Dual Cyclooxygenase-2 and Carbonic Anhydrase Inhibition
Augmented Macular Pigment-containing Nutraceutical and Central Visual Function
Intravitreal Ranibizumab (Lucentis®) in the Treatment of Non-leaking Macular Cysts in Retinal Dystro…
Efficacy and Safety of Topically Applied Medical Therapy for the Treatment of Pediatric Glaucoma
Management of Cystoid Macular Edema Secondary to Retinitis Pigmentosa Via Subliminal Micropulse Yell…
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ